Mayo Clinic

Futó vizsgálatok

• Még nem toboroz

  Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

  NCT07843420· 2. fázis· Forrás

• Toboroz

  A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

  NCT07309445· Forrás

• Toboroz

  A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

  NCT07359820· 2. fázis· Forrás

• Fut, nem toboroz

  INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

  NCT07543367· Forrás

• Toboroz

  A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  NCT07424833· 1. fázis· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· 3. fázis· Forrás

• Toboroz

  A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

  NCT07219212· 1. fázis· Forrás

• Toboroz

  Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

  NCT07012148· Korai 1. fázis· Forrás

• Toboroz

  Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  NCT07252232· 3. fázis· Forrás

• Toboroz

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  NCT07222800· 3. fázis· Forrás

• Toboroz

  ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  NCT07007559· 2. fázis· Forrás

• Toboroz

  Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

  NCT07192432· 1/2. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  NCT07085104· 1. fázis· Forrás

• Toboroz

  A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

  NCT07027514· 1. fázis· Forrás

• Toboroz

  A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  NCT06989437· 2/3. fázis· Forrás

• Még nem toboroz

  Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

  NCT06973629· 3. fázis· Forrás

• Toboroz

  Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

  NCT06668493· 1/2. fázis· Forrás

• Toboroz

  A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT06533644· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  NCT06682793· 1/2. fázis· Forrás

• Toboroz

  Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  NCT07227246· 3. fázis· Forrás

• Meghívásos bevonás

  Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

  NCT06868459· Forrás

• Toboroz

  Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

  NCT06752577· Forrás

• Toboroz

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· 2. fázis· Forrás

• Toboroz

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

  NCT06381141· 1. fázis· Forrás

• Fut, nem toboroz

  A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

  NCT06413498· 3. fázis· Forrás

• Fut, nem toboroz

  PREVENT ALL ALS Study

  NCT06581861· Forrás

• Toboroz

  ASSESS ALL ALS Study

  NCT06578195· Forrás

• Fut, nem toboroz

  A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

  NCT06414603· Forrás

• Toboroz

  A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  NCT06395519· 1/2. fázis· Forrás

• Fut, nem toboroz

  Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

  NCT06267391· Forrás

• Fut, nem toboroz

  SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

  NCT06325748· 1. fázis· Forrás

• Fut, nem toboroz

  Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS

  NCT06392126· 1/2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  NCT06051695· 1/2. fázis· Forrás

• Toboroz

  RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  NCT06121297· 1/2. fázis· Forrás

• Toboroz

  A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

  NCT06072482· 4. fázis· Forrás

• Fut, nem toboroz

  TheraSphere With Durvalumab and Tremelimumab for HCC

  NCT05063565· 2. fázis· Forrás

• Toboroz

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· 3. fázis· Forrás

• Fut, nem toboroz

  Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

  NCT05899608· 3. fázis· Forrás

• Fut, nem toboroz

  A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

  NCT05873686· 1. fázis· Forrás

• Toboroz

  Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

  NCT05636618· 1/2. fázis· Forrás

• Toboroz

  Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  NCT05951179· 2. fázis· Forrás

• Toboroz

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· 3. fázis· Forrás

• Toboroz

  MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

  NCT05655312· 1/2. fázis· Forrás

• Toboroz

  FOG-001 in Locally Advanced or Metastatic Solid Tumors

  NCT05919264· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

  NCT05585320· 1/2. fázis· Forrás

• Fut, nem toboroz

  Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

  NCT05497804· 2. fázis· Forrás

• Toboroz

  Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  NCT05519449· 1. fázis· Forrás

• Fut, nem toboroz

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

  NCT05047172· 3. fázis· Forrás

• Toboroz

  Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  NCT05245500· 1. fázis· Forrás

Showing 50 of 85.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák6 toboroz
• Amiotrófiás laterálszklerózis (ALS)4 toboroz
• Hasnyálmirigyrák4 toboroz
• Hólyagrák4 toboroz
• Prosztatarák4 toboroz
• Tüdőrák4 toboroz
• Krónikus limfoid leukémia (CLL)3 toboroz
• Máj- és epeúti rák3 toboroz
• Méhtestrák3 toboroz
• Petefészekrák3 toboroz
• Stroke (szélütés)3 toboroz
• Szarkóma3 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Lupus (SLE)2 toboroz
• Mezotelióma2 toboroz
• Rheumatoid arthritis2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Alzheimer-kór1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Áttétes emlőrák1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Epilepszia1 toboroz
• Follikuláris limfóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Krónikus vesebetegség1 toboroz
• Lewy-testes demencia1 toboroz
• Méhnyakrák1 toboroz
• Melanóma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pitvarfibrilláció1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Szívelégtelenség1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)

  NCT07240831· Forrás

• Leállították

  Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery

  NCT06280092· Korai 1. fázis· Forrás

• Lezárult

  Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

  NCT06604442· 4. fázis· Forrás

• Lezárult

  Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

  NCT06331624· 2. fázis· Forrás

• Lezárult

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· 3. fázis· Forrás

• Lezárult

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Forrás

• Leállították

  ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

  NCT06026332· Forrás

• Lezárult

  Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer

  NCT05890872· Forrás

• Lezárult

  Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy

  NCT05486338· Forrás

• Lezárult

  Acorai Machine Learning Generalization (MLG) Study

  NCT05835024· Forrás

• Leállították

  Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

  NCT05980416· 1. fázis· Forrás

• Lezárult

  A Phase 1 Study of BMF-500 in Adults With Acute Leukemia

  NCT05918692· 1. fázis· Forrás

• Lezárult

  Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

  NCT05085990· 1. fázis· Forrás

• Leállították

  Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

  NCT05819827· Forrás

• Lezárult

  A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

  NCT05517603· 1/2. fázis· Forrás

• Lezárult

  MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer

  NCT05189171· Forrás

• Lezárult

  TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

  NCT04998305· 1/2. fázis· Forrás

• Lezárult

  Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

  NCT05190744· 2. fázis· Forrás

• Lezárult

  A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

  NCT04919512· 2. fázis· Forrás

• Lezárult

  Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.

  NCT05243862· 2. fázis· Forrás

• Leállították

  A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

  NCT05269355· 2/3. fázis· Forrás

• Leállították

  A Study of HFB301001 in Adult Patients With Advanced Solid Tumors

  NCT05229601· 1. fázis· Forrás

• Leállították

  A Study to Investigate LYL797 in Adults With Solid Tumors

  NCT05274451· 1. fázis· Forrás

• Lezárult

  Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

  NCT05085977· 1. fázis· Forrás

• Leállították

  XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

  NCT05038644· 1. fázis· Forrás

• Leállították

  Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer

  NCT04958785· 2. fázis· Forrás

• Lezárult

  XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT05005728· 2. fázis· Forrás

• Leállították

  A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis

  NCT04948645· 1. fázis· Forrás

• Leállították

  Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

  NCT04506086· 4. fázis· Forrás

• Leállították

  Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT04816604· 2. fázis· Forrás

• Lezárult

  Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

  NCT04484142· 2. fázis· Forrás

• Lezárult

  Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

  NCT04260126· 2. fázis· Forrás

• Lezárult

  The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma

  NCT04760405· Forrás

• Lezárult

  Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

  NCT04471844· Forrás

• Toboroz

  Evaluate the Safety and Clinical Activity of HH2853

  NCT04390737· 1/2. fázis· Forrás

• Lezárult

  REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

  NCT04526106· 1/2. fázis· Forrás

• Leállították

  Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

  NCT04305444· 2. fázis· Forrás

• Lezárult

  Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

  NCT04000971· Forrás

• Toboroz

  Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  NCT03907046· 3. fázis· Forrás

• Leállították

  NOLA (NeuWave Observational Liver Ablation) Registry

  NCT04107766· Forrás

• Lezárult

  iCLAS™ for Persistent Atrial Fibrillation

  NCT04061603· Forrás

• Lezárult

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· 4. fázis· Forrás

• Lezárult

  Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

  NCT03829020· 1. fázis· Forrás

• Lezárult

  Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

  NCT03837327· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

  NCT03201965· 3. fázis· Forrás

• Lezárult

  Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

  NCT02924402· 1. fázis· Forrás

• Lezárult

  Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

  NCT02831959· 3. fázis· Forrás

• Leállították

  Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

  NCT02629692· 1/2. fázis· Forrás

• Lezárult

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Forrás

• Leállították

  Liver and Biliary Tumor Tissue Registry

  NCT02917759· Forrás